Skip to main content
. 2022 Sep 18;29(9):6688–6699. doi: 10.3390/curroncol29090525

Figure 2.

Figure 2

Impact of circ_0059707 expression on overall survival. (A) Non-M3 AML patients; (B) non-M3 AML patients, age >= 60 years; (C) non-M3 AML patients, younger than 60 years; (D) non-M3 female AML patients; (E) non-M3 male AML patients; (F) non-M3 male AML patients, age < 60 years.